Welcome back to episode sixteen of the Dr. Spidey podcast. This week, Dr. Spidey and his co-host Gwen step away from breast surgery to tackle a neurological ticking time bomb on the acute medical take: Transient Ischemic Attacks (TIAs) and secondary stroke prevention. Tailored specifically for medical students, junior doctors, and international medical graduates preparing for high-stakes exams like the UKMLA and PLAB, this episode delivers a high-yield, commute-friendly clinical breakdown designed to permanently update your outdated guidelines.

The clinical journey begins by redefining TIAs through a modern tissue-based lens, before completely dismantling a historic medical school trap. The hosts emphasize that NICE guidelines have officially scrapped the famous ABCD2 score for triaging TIAs. Listeners will learn the new golden rule: all suspected TIAs mandate an immediate loading dose of Aspirin 300 mg (unless contraindicated) and an urgent specialist assessment within 24 hours, completely regardless of age or symptom severity.

Moving into long-term management, the conversation outlines the definitive secondary cardiovascular prevention bundle—switching to lifelong Clopidogrel 75 mg, initiating high-intensity Atorvastatin 80 mg, and enforcing tight blood pressure control below 130/80. Dr. Spidey and Gwen then deliver a surgical masterclass on Carotid Endarterectomy, breaking down the strict NASCET criteria that limits surgical intervention to the "sweet spot" of 50 to 99 percent symptomatic stenosis, provided it is performed within the crucial two-week window.

The hosts also highlight the absolute necessity of hunting for Atrial Fibrillation with an ECG, explaining why finding an irregular rhythm demands a complete pivot from antiplatelets to full anticoagulation. Finally, the episode wraps up with a major announcement and teaser for next week’s launch of an exclusive multi-part series on Obstetrics and Gynecology.

Thank you for being an essential part of our founding family. If you found this neuro-vascular breakdown helpful, please subscribe to the channel and share the episode with your clinical study groups. Keep reading, keep questioning, and always keep practicing with compassion.

Welcome back to episode fifteen of the Dr. Spidey podcast. This week, Dr. Spidey and his co-host Gwen tackle a vital staple of primary care and surgery: benign breast diseases and breast cancer. Tailored specifically for medical students, junior doctors, and international medical graduates preparing for high-stakes exams like the UKMLA and PLAB, this episode delivers a high-yield, commute-friendly clinical breakdown.

The clinical journey begins by distinguishing harmless benign conditions—such as the rubbery, mobile fibroadenoma ("breast mouse" in patients under 30), smoking-linked duct ectasia, and cyclical fibrocystic changes—from malignant pathology using the gold-standard Triple Assessment combining clinical examination, age-stratified imaging (ultrasound under 35, mammography over 35), and core needle biopsy.
The core of the episode maps out the critical NICE 2-Week Wait (2WW) suspected cancer referral triggers, highlighting why an unexplained breast lump in patients aged 30 and over, skin changes like peau d'orange, or unexplained unilateral nipple changes in those 50 and over mandate immediate urgent specialist referral.

The conversation then explores invasive breast cancer pathology, contrasting Invasive Ductal Carcinoma (IDC) with Invasive Lobular Carcinoma (ILC), while breaking down how receptor status dictates targeted medical management:

• ER & PR Positive: Treated with endocrine therapies like Tamoxifen or Aromatase inhibitors.
  
• HER2 Positive: Revolutionized by targeted monoclonal antibody therapy like Trastuzumab (Herceptin).
  
• Triple-Negative: Highly aggressive cancers relying on traditional chemotherapy and surgery.
  

Finally, the episode wraps up with a teaser for next week’s leap into neurology, focusing on transient ischemic attacks (TIAs) and carotid endarterectomy. Thank you for being an essential part of our founding family. If you found this breast health breakdown helpful, please subscribe to the channel and share the episode with your clinical study groups. Keep reading, keep questioning, and always keep practicing with compassion.

Hey! I'd love to hear your thoughts, send me a voice note.

Welcome back to episode fourteen of the Dr. Spidey podcast. This week, Dr. Spidey and his co-host Gwen leave the liver behind to dive headfirst into the fiery, unpredictable world of the bowels, tackling Inflammatory Bowel Disease (IBD). Tailored specifically for medical students, junior doctors, and international medical graduates preparing for high-stakes exams like the UKMLA and PLAB, this episode delivers a high-yield, commute-friendly breakdown comparing and contrasting Crohn’s Disease and Ulcerative Colitis.

The clinical journey begins by mapping out the fundamental differences through three core lenses: anatomical distribution, depth of tissue inflammation, and histological appearance. The hosts explain how Ulcerative Colitis (UC) is strictly restricted to the colon and rectum, spreading continuously upward with superficial mucosal inflammation that leads to the classic "lead pipe" colon on imaging. In contrast, they highlight how Crohn’s Disease can strike anywhere from the mouth to the anus with discontinuous "skip lesions" and deep, transmural inflammation that drives strictures, abscesses, and complex fistulas.

The conversation explores the distinct clinical presentations, contrasting the bloody diarrhea and tenesmus of UC with the right lower quadrant pain, weight loss, and terminal ileum B12 malabsorption characteristic of Crohn’s. The core of the episode tackles the acute management of severe flares using the Truelove and Witts criteria, detailing the stepped approach of high-dose IV corticosteroids, daily monitoring to avoid toxic megacolon, and rescue therapies like IV ciclosporin or Infliximab.

Crucially, the episode highlights two major exam-defining pearls:

• The Surgical Rule: Surgery is completely curative for Ulcerative Colitis (removing the colon cures the disease), whereas surgery is not curative for Crohn's Disease due to its patchy, widespread nature.
• The Smoking Paradox: Nicotine is oddly protective in Ulcerative Colitis (patients often flare after quitting), but it acts as absolute poison in Crohn's Disease, driving disease severity and surgical recurrence.

Finally, the episode wraps up with a teaser for next week’s leap into breast, starting with benign and malignant lesions. Thank you for being an essential part of our founding family. If you found this IBD breakdown helpful, please subscribe to the channel and share the episode with your clinical study groups. Keep reading, keep questioning, and always keep practicing with compassion.

Background Score Credits:

Song: Cartoon, Jéja - On & On (feat. Daniel Levi) [NCS Release]Music provided by NoCopyrightSoundsFree Download/Stream: http://ncs.io/onandonWatch: http://youtu.be/K4DyBUG242c